157 related articles for article (PubMed ID: 8192496)
21. [Urine examination for tumor cells using quantitative immunocytochemistry. Antibodies to a CEA-like antigen].
Sautner D; Saeger W
Fortschr Med; 1995 May; 113(14):207-9. PubMed ID: 7607589
[TBL] [Abstract][Full Text] [Related]
22. [Usefulness of P53 oncoprotein in urinary wash cytology: experience in patients with superficial bladder carcinoma].
Moreno Sierra J; Luengo Alpuente S; López García-Asenjo J; Redondo González E; Blanco Jiménez E; Fernández Pérez C; Silmi Moyano A; Resel Estévez L
Arch Esp Urol; 1999 Nov; 52(9):943-54. PubMed ID: 10633962
[TBL] [Abstract][Full Text] [Related]
23. Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas.
Feil G; Wechsel HW; Nelde HJ; Bichler KH
Anticancer Res; 1999; 19(4A):2591-7. PubMed ID: 10470200
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
Feil G; Zumbrägel A; Päulgen-Nelde HJ; Hennenlotter J; Maurer S; Krause S; Bichler KH; Stenzl A
Anticancer Res; 2003; 23(2A):963-7. PubMed ID: 12820331
[TBL] [Abstract][Full Text] [Related]
25. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study].
Lanzafame S; Puzzo L; Di Naso C; Di Marco G; Ranno S; Minardi G
Pathologica; 1986; 78(1056):451-8. PubMed ID: 3302887
[No Abstract] [Full Text] [Related]
26. Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma.
Pariente JL; Bordenave L; Michel P; Latapie MJ; Ducassou D; Le Guillou M
J Urol; 1997 Aug; 158(2):338-41. PubMed ID: 9224298
[TBL] [Abstract][Full Text] [Related]
27. Initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder.
Sánchez-Carbayo M; Herrero E; Megias J; Mira A; Espasa A; Chinchilla V; Soria F
J Urol; 1999 Apr; 161(4):1110-5. PubMed ID: 10081849
[TBL] [Abstract][Full Text] [Related]
28. ABO blood groups and their relationship to transitional cell carcinoma of the urinary bladder in 30 Jordanian patients.
Murshidi MS
Acta Urol Belg; 1988; 56(4):517-22. PubMed ID: 3207084
[No Abstract] [Full Text] [Related]
29. Relationship of blood groups and transitional cell carcinoma of the bladder.
Kirkali Z; Eryigit M
Int Urol Nephrol; 1993; 25(3):255-7. PubMed ID: 8225826
[TBL] [Abstract][Full Text] [Related]
30. [A case of transitional cell carcinoma of renal pelvis with extremely high serum levels of CA19-9 and CEA].
Sugaya Y; Ochi M; Hashimoto S; Muraki J; Morita T; Kobayashi Y; Nakamura S; Tokue A
Hinyokika Kiyo; 1997 Jul; 43(7):495-9. PubMed ID: 9282296
[TBL] [Abstract][Full Text] [Related]
31. [The proliferating nuclear fraction as a prognostic factor in superficial bladder carcinomas].
Belloso L; Zugasti A; Urkia M; Arozena F; Blasco-Olaetxea E
Arch Esp Urol; 1997 Oct; 50(8):831-6. PubMed ID: 9463280
[TBL] [Abstract][Full Text] [Related]
32. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer.
Margel D; Tal R; Baniel J
J Urol; 2007 Dec; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody CIBCHTB1 defining an epitope on carcinoembryonic antigen (CEA).
Meenakshi A; Kumar NS; Vijayshanker SG
Hum Antibodies; 2000; 9(4):223-9. PubMed ID: 11341176
[TBL] [Abstract][Full Text] [Related]
35. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
36. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. Criteria for the loss of BGA based on the staining pattern by the PAP method and its correlation with CEA and fibronectin].
Nasu Y
Nihon Hinyokika Gakkai Zasshi; 1986 Jun; 77(6):977-87. PubMed ID: 3534405
[No Abstract] [Full Text] [Related]
37. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
Bkhatta AD; Makhlin NV
Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
[No Abstract] [Full Text] [Related]
38. Serum and urine ferritin in patients with transitional cell carcinoma of the bladder.
Migliari R; Mela Q; Ruggiero V; Scarpa RM; Migliari M; Pitzus F; Usai E
Arch Ital Urol Nefrol Androl; 1991 Mar; 63(1):141-5. PubMed ID: 1830406
[TBL] [Abstract][Full Text] [Related]
39. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
[TBL] [Abstract][Full Text] [Related]
40. [A case of transitional cell carcinoma of the renal pelvis with adenocarcinoma producing CEA and CA19-9].
Matsuoka Y; Ishimaru H; Arai G; Aida J; Okada Y; Ito Y
Hinyokika Kiyo; 2004 Sep; 50(9):637-40. PubMed ID: 15518131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
